As previously reported, Guggenheim downgraded Enphase Energy (ENPH) “back” to Sell from Neutral with a $73 price target ...

Wedbush reissued their outperform rating on shares of Adicet Bio (NASDAQ:ACET – Free Report) in a report issued on Thursday,RTT News reports. They currently have a $5.00 price objective on the stock.

Equities researchers at StockNews.com started coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Get Free Report) in a ...

3.2% in Monday's trading to near a 52-week low as Guggenheim downgrades units to Neutral from Buy with a $22 price target, slashed from $37, citing last week's "lackluster" earnings report "with ...

Guggenheim raised the firm’s price target on Kontoor Brands (KTB) to $100 from $80 and keeps a Buy rating on the shares. Given improved ...

On Wednesday, Rhythm Pharmaceuticals Inc (RYTM) stock saw a modest uptick, ending the day at $62.65 which represents a slight increase of $6.40 or 11.38% from the prior close of $56.25. The stock ...

On Friday, Guardant Health Inc (GH) stock saw a modest uptick, ending the day at $28.61 which represents a slight increase of $0.02 or 0.07% from the prior close of $28.59. The stock opened at $28.58 ...

The live webcast will be accessible via “Events & Presentations” on the Investor Relations section of Zevra’s website at investors.zevra.com. About Zevra Therapeutics, Inc.

JENA, Germany, Oct. 31, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory ...